Metoprolol Succinate Tablet, Extended Release
Product Images NDC 68001-360

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68001-360). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

65d59c7d 3d7e 4210 Af08 7bb02029294a 00

A forest plot titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals comparing Metoprolol Succinate Extended-Release Tablets to Placebo across various subgroups for three outcomes: Total Mortality, Total Mortality or All-Cause Hospitalization, and Total Mortality or Hospitalization for Heart Failure. Subgroups include location (US/non-US), NYHA class, ejection fraction, ischemic etiology, sex, race, previous myocardial infarction, diabetes status, hypertension history, and heart rate categories.*

FDA Label Image

Image-01 (Image 01)

Chemical structure diagram of the active ingredient Metoprolol Succinate, showing its molecular components and arrangement.*

FDA Label Image

Metoprolol Succinate Extended-release Tablets, Usp Label 25mg 100ct Bottle Rev 05 2018.jpg (Image 04)

Label for Metoprolol Succinate Extended-Release Tablets USP, 25 mg strength, containing 100 tablets. The label indicates the product is manufactured by Novast Laboratories Ltd. for BluePoint Laboratories, with storage instructions and warnings included. It features the NDC 68001-356-00 and specifies it is a prescription-only medication.*

FDA Label Image

Metoprolol Succinate Extended-release Tablets, Usp Label 50mg 100ct Bottle Rev 05 2018.jpg (Image 05)

Packaging label for BluePoint Laboratories Metoprolol Succinate Extended-Release Tablets USP, 50 mg strength. The label indicates a package count of 100 tablets. It includes dosage form as extended-release tablets, manufacturer information (Novast Laboratories Ltd., Nantong, China), and storage instructions. The label also features NDC code 68001-357-00 and a barcode.*

FDA Label Image

Metoprolol Succinate Extended-release Tablets, Usp Label 100mg 100ct Bottle Rev 05 2018.jpg (Image 06)

Packaging label for Bluepoint Metoprolol Succinate Extended-Release Tablets, USP 100 mg. The label indicates a count of 100 tablets, manufactured by Novast Laboratories Ltd. for Bluepoint Laboratories. The label includes dosage strength, storage instructions, a barcode, and a note that the medication is Rx only.*

FDA Label Image

S:\departments\bplabs\quality & Regulatory\regulatory\artwork Files Bluepoint\ingenust Novast Laboratories Ltd\metoprolol Succinate Er\approved\metoprolol Succinate Extended-release Tablets, Usp Label 200mg 100ct Bottle Rev 05 2018.jpg (Image 07)

Label for Metoprolol Succinate Extended-Release Tablets USP, 200 mg strength, by BluePoint Laboratories. The label indicates a package size of 100 tablets and includes storage instructions, a barcode, and the manufacturer details (Novast Laboratories Ltd, Nantong, China). The label states the dosage form as extended-release tablets and has a blue and white color scheme.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.